Search clinical trials for: Norepinephrine reuptake inhibitor

Total 68111 results

Axsome Therapeutics, Inc.

Recruiting

Elucidating TAAR-1, Dopamine, and Norepinephrine in Binge Eating Disorder Using Solriamfetol (ENGAGE)

Binge-Eating Disorder

United States
Axsome Therapeutics, Inc.

Recruiting

SUNOSI® (Solriamfetol) Pregnancy Registry

Obstructive Sleep Apnea | Narcolepsy | Pregnant Women and Their Offspring

United States
Axsome Therapeutics, Inc.

Recruiting

Progressing TAAR-1, Dopamine, and Norepinephrine in Depression Using Solriamfetol (PARADIGM)

Major Depressive Disorder

United States
Axsome Therapeutics, Inc.

Recruiting

A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms

Major Depressive Disorder

United States
Axsome Therapeutics, Inc.

Recruiting

A Study to Access the Efficacy and Safety of Solriamfetol in Subjects With ADHD (FOCUS)

ADHD

United States
Wake Forest University Health Sciences

Recruiting

Serotonin-norepinephrine Reuptake Inhibitor in Prophylaxis of Depression Following Fragility Fractures (SNRI)

Depression in Old Age | Fragility Fracture

United States
Janssen Research & Development, LLC

Recruiting

A Study in Participants With Major Depressive Disorder (MDD) With Anhedonia and Inadequate Response to Current Antidepressant Therapy Including a Selective Serotonin Reuptake Inhibitor (SSRI) or Serotonin Norepinephrine Reuptake Inhibitor (SNRI) (VENTURA-RWE)

Depressive Disorder, Major

United States, Korea, Republic of, Spain, Argentina, United Kingdom, Sweden, Italy, Germany, France, Canada, Brazil
Göteborg University
Arvid Carlsson Research AB

Recruiting

OSU6162 as add-on in SSRI/SNRI-resistant Depression (ODEN)

Depressive Disorder | Depression | Depressive Disorder, Treatment-Resistant | Depressive Episode | Recurrent Depressive Disorder | Recurrent Depression

Sweden
Adams Clinical

Recruiting

Tracking Response to Antidepressants in Advance of Investigational Trials (TRAIT)

Major Depressive Disorder

United States
Xijing Hospital

Recruiting

Neuroimaging Guided and Robot-assisted rTMS for Suicidal Ideation of Depression

Depression | Suicidal Ideation

China
University Hospital, Lille

Recruiting

Evaluation of the Initial Prescription of Ketamine and Milnacipran in Depression in Patients With a Progressive Disease (KETAPAL)

Depression

France
University of Washington
Patient-Centered Outcomes Research Institute; Boston University; Washington State... and other collaborators

Active, not recruiting

Sequenced Treatment Effectiveness for Posttraumatic Stress (STEPS)

PTSD

United States
Dr. Nazanin Alavi
Online PsychoTherapy Clinic

Completed

Efficacy of Online CBT for GAD Compared to Pharmaceutical Interventions

Generalized Anxiety Disorder

Canada
Janssen Research & Development, LLC

Terminated

A Standard of Care Study of Patients With Major Depressive Disorder Who Have Had an Inadequate Response to a Selective Serotonin Reuptake/Serotonin-Norepinephrine Reuptake Inhibitor Antidepressant

Depressive Disorder, Major

United States, United Kingdom
Indiana University
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

eIMPACT-DM Pilot Trial: Depression Treatment to Reduce Diabetes Risk

Depression | Insulin Resistance | PreDiabetes | Type 2 Diabetes | Depressive Symptoms | Major Depressive Disorder | Dysthymic Disorder

United States
Janssen-Cilag International NV

Completed

A Long-term Comparison of Esketamine Nasal Spray Versus Quetiapine Extended Release, Both in Combination With a Selective Serotonin Reuptake Inhibitor/Serotonin-Norepinephrine Reuptake Inhibitor, in Participants With Treatment Resistant Major Depressive Disorder (ESCAPE-TRD)

Depressive Disorder, Major

Israel, Hungary, Korea, Republic of, Taiwan, Portugal, Turkey, Germany, Malaysia, Denmark, Bulgaria, Czechia, Belgium, Poland, Brazil, Netherlands, Argentina, Finland, Greece, South Africa, Austria, Kazakhstan, Norway, Sweden, United...
Indiana University
National Heart, Lung, and Blood Institute (NHLBI)

Completed

eIMPACT Trial: Modernized Collaborative Care to Reduce the Excess CVD Risk of Older Depressed Patients

Depression | Heart Diseases | Cardiovascular Diseases | Coronary Artery Disease | Stroke | Depressive Symptoms | Major Depressive Disorder | Dysthymic Disorder

United States
Medical University of South Carolina
American Hearing Research Foundation; Cures within Reach Foundation

Completed

Assessing the Efficacy of a Serotonin and Norepinephrine Reuptake Inhibitor for Improving Meniere's Disease Outcomes

Meniere Disease

United States
Janssen Research & Development, LLC

Completed

A Study to Compare the Efficacy, Safety, and Tolerability of JNJ-42847922 Versus Quetiapine Extended-Release as Adjunctive Therapy to Antidepressants in Adult Participants With Major Depressive Disorder Who Have Responded Inadequately to Antidepressant Therapy

Depressive Disorder, Major

United States
Adams Clinical

Completed

Tracking Response to Antidepressants in Advance of Investigational Trials, Relapse Study (TRAIT-RS)

Major Depressive Disorder

United States
Boston Medical Center

Withdrawn

Duloxetine Tibial Plateau

Pain, Postoperative | Tibial Plateau Fracture

United States
Axsome Therapeutics, Inc.

Completed

A Trial of AXS-05 in Patients With Major Depressive Disorder (GEMINI)

Depression | Major Depressive Disorder

United States
Axsome Therapeutics, Inc.

Completed

Open-Label Safety Study of AXS-05 in Subjects With Depression

Depression | Major Depressive Disorder | Treatment Resistant Depression

United States
Jazz Pharmaceuticals

Withdrawn

Study of the Safety and Efficacy of Nabiximols Oromucosal Spray Versus Placebo in Patients With Post-traumatic Stress Disorder

Post-Traumatic Stress Disorder
Hospital Clinic of Barcelona

Completed

Risk Factors for AD-Associated Switch to Mania

Bipolar Disorder

Spain
University of Ottawa
Allergan

Active, not recruiting

Levomilnacipran in Healthy Males

None (i.e. Healthy Volunteers)

Canada
Centre Hospitalier Rouffach
University Hospital, Strasbourg, France

Unknown

Effects of the Addition of Metyrapone to Antidepressant Therapy in Depression With Dexamethasone Suppression Test Non-suppression.

Depressive Disorder | Hormone Disturbance

France
Shanghai Mental Health Center
RenJi Hospital; Huashan Hospital; Shanghai 10th People's Hospital; Shanghai Jiao... and other collaborators

Unknown

Optimization of Diagnosis and Treatment of Depression Based on Multidimensional Clinical Assessment Classification

Major Depressive Disorder

China
Shanghai Mental Health Center
Guangzhou Psychiatric Hospital; Shanghai Jiao Tong University School of Medicine and other collaborators

Unknown

A Study of Individualized Diagnosis and Treatment for Major Depressive Disorder With Atypical Features

Major Depressive Disorder

China
The Cleveland Clinic

Completed

Differentiating Unipolar and Bipolar Depression in Young Adults Using fMRI

Bipolar Disorder | Major Depression

United States
Second Affiliated Hospital, School of Medicine,...

Unknown

MRI Study of Antidepressants in the Treatment of Refractory Functional Dyspepsia

Therapeutic Mechanism of Antidepressants for Refractory FD

China
Forest Laboratories
Cypress Bioscience, Inc.

Terminated

Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia (MyFi)

Primary Fibromyalgia

United States
Rambam Health Care Campus

Unknown

Prediction of Inter-individual Differences in the Response to Morphine Versus Milnacipran in Patients With Sciatica

Neuropathic Pain

Israel
Seoul National University Hospital

Unknown

Pre-emptive Effect of Duloxetine in the Second Knee in Staged Total Knee Arthroplasty

Knee Osteoarthritis

Korea, Republic of
University of North Texas Health Science Center

Completed

The Use of Duloxetine for Cognition Improvement in Individuals With Mild Cognitive Impairment (DEMO)

Depression | Mild Cognitive Impairment

United States
University of Pennsylvania
National Institute of Mental Health (NIMH)

Completed

Effectiveness of Long-Term Versus Short-Term Treatment of Generalized Anxiety Disorder With Venlafaxine XR

Anxiety Disorders

United States
prof. Peter de Jonge

Unknown

Initial Severity and Antidepressant Efficacy for Anxiety Disorders: an Individual Patient Data Meta-analysis

Anxiety Disorders | Generalized Anxiety Disorder | Social Anxiety Disorder | Panic Disorder | Post-traumatic Stress Disorder | Obsessive-compulsive Disorder
Canadian Network for Observational Drug Effect...
Canadian Institutes of Health Research (CIHR); Drug Safety and Effectiveness...

Completed

Serotonin-norepinephrine Reuptake Inhibitors and Acute Kidney Injury (SNRI-AKI)

Depression | Acute Kidney Injury

Canada
Euthymics BioScience, Inc.

Completed

A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)

Major Depressive Disorder

United States
Duke University
National Institute of Mental Health (NIMH)

Completed

Antidepressant Safety in Kids Study (ASK)

Obsessive Compulsive Disorder | Anxiety Disorders | Eating Disorders | Depressive Disorders

United States
Duke University

Completed

Switching From Generic Selective Serotonin Reuptake Inhibitors (SSRIs) and Selective Serotonin and Norepinephrine Reuptake Inhibitors (SNRIs) to Three Different Dose Initiation Strategies With Vilazodone

Major Depressive Disorder (MDD)

United States
Massachusetts General Hospital

Completed

Duloxetine for Social Anxiety Disorder: Prediction of Long Term Outcome

Anxiety Disorder

United States
Pamlab, Inc.
Baylor Health Care System; Red Oak Psychiatry Associates, PA

Completed

Combination Deplin® and Antidepressant Therapy for a Major Depressive Episode (MDE)- a Retrospective Analysis

Major Depressive Disorder

United States
Forest Laboratories
Cypress Bioscience, Inc.

Terminated

Long-Term Safety and Efficacy Study of Milnacipran in Pediatric Patients With Primary Fibromyalgia (MyFi)

Primary Fibromyalgia

United States
University Hospital, Basel, Switzerland

Completed

Interaction Between Duloxetine and 3,4-Methylenedioxymethamphetamine (MDMA, Ecstasy)

Substance-Related Disorders | Amphetamine-Related Disorders | Mood Disorder

Switzerland
Analgesic Solutions
Forest Laboratories

Unknown

Study to Evaluate the Efficacy of Milnacipran in the Treatment of Pain Due to Osteoarthritis

Osteoarthritis

United States
University of Ottawa

Unknown

Effectiveness of the Dual Serotonin Norepinephrine Reuptake Inhibitor Desvenlafaxine Succinate in Healthy Volunteers (DVS)

Healthy

Canada
Eli Lilly and Company

Completed

Evaluation of the Effects of Duloxetine on Norepinephrine

Major Depressive Disorder

United States
Sunnybrook Health Sciences Centre

Not yet recruiting

Effect of peRiopErative duLoxetIne Administration on Opioid Consumption Following Total kneE Arthroplasty (RELIFE) (RELIFE)

Knee Osteoarthritis

Canada
University of Oxford

Not yet recruiting

7T Amygdala and Citalopram Study (7TAC)

Depressive Disorder | Depression | Mood Disorders | Cognition | Emotional Processing

Search clinical trials for: Norepinephrine reuptake inhibitor

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Togo

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations